The Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) at Mayo Clinic is excited to announce a new Phase II clinical trial for infants diagnosed with HLHS before birth. This clinical trial uses stem cells collected from the baby’s own umbilical cord blood (UCB) at [...]
NEW ORLEANS -- Mayo Clinic's Todd and Karen Wanek Family Program for Hypoplastic Left Heart Syndrome (HLHS) and Ochsner Hospital for Children are proud to announce their collaboration to prevent heart failure in HLHS, a rare and complex form of congenital heart disease.
Ochsner's Pediatric and Adult Congenital [...]
Demystifying Clinical Trials -- Part 2
The clinical research world can sometimes seem confusing. Research teams have many people in different roles, and they may use words that are unfamiliar to people outside of research work.
The guide below defines some commonly used words and phrases. Let us [...]
In honor of Clinical Trials day on May 20th, we’re kicking off a series that's designed to shed some light on the world of clinical research. Follow us on Facebook, Twitter, and Instagram and stay tuned for posts over the coming months about commonly confusing terms, questions to ask [...]
Many hypoplastic left heart syndrome (HLHS) and congenital heart defect families have experienced the love and support that overflow in Ronald McDonald Houses (RMH) around the world. With 368 houses in 64 countries, patients and families are thankful to call the House a home when medical care [...]